Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded an increase of 3.79%. However, over the last six
CRISPR Therapeutics AG (CRSP) currently has a stock price of $53.62. The stock saw a sharp increase in the last trading session, hitting a high of $268.0 after opening at $54.24. The lowest recorded price for the day was $32.0 before it closed at $52.73.
In terms of market performance, CRISPR Therapeutics AG had a fairly even. The highest value for the stock in the past year was $63.68 on 07/16/24, and the lowest value was recorded at $30.04 on 04/07/25. 52-week price history of CRSP Stock Studying a stock’s
Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. CRISPR Therapeutics AG’s current trading price is -19.16% away from its 52-week high, while its distance from the 52-week low is 71.37%.
CRISPR Therapeutics AG experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $63.68 on 07/16/24, while the lowest price for the same period was registered at $30.04 on 04/07/25. 52-week price history of CRSP Stock A stock’s
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. CRISPR Therapeutics AG’s current trading price is -31.40% away from its 52-week high, while its distance from the 52-week low is 45.42%. The stock’s price
Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. CRISPR Therapeutics AG’s current trading price is -43.18% away from its 52-week high, while its distance from the 52-week low
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded a decrease of -4.35%. However, over the last six months,
All rights reserved © 2024, Powered By Smart TechOne